Two-dose shot approved for Canadian adults.
Another COVID-19 vaccine has been approved for use in Canada.
Health Canada has authorized the two-dose Novavax Nuvaxovid vaccine for people aged 18 and older.
Clinical trails suggest the shot is 90 percent effective in protecting from symptomatic COVID-19 cases, and 100 percent effective in preventing severe disease, according to a release from the agency.
The vaccine's safety and effectiveness for children has not yet been determined.
Health Canada is recommending the two doses be administered 21 days apart.
GM Investing in St. Catharines
NRP Investigating Fatal Pelham Crash
NRP Officers Praised by Management
945 Supportive Housing Units Approved
Niagara Talks Canadian Defense
Niagara Falls Expecting More Evacuees
St. Catharines Man Charged with Voyuerism
Candidate Registration Approaches